LeMaitre Vascular, Inc. (LMAT) Q2 2021 Earnings Results

Lemaitre Vascular Beats on EPS, Stock Down 0.22%

Lemaitre Vascular's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted slightly negatively, down 0.22%, likely due to the lack of revenue data and guidance. Investors may be cautious given ongoing supply chain challenges, despite management's optimistic outlook on demand and innovation.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.40	N/A	+19.40%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed confidence in the company's product demand despite supply chain issues. They emphasized the importance of innovation for future growth.

Management highlighted strong demand for vascular products.

They noted ongoing challenges in the supply chain but remain focused on growth.

Future investments in technology were discussed as a priority.

Lemaitre Vascular Beats on EPS, Stock Down 0.22%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Beats on EPS, Stock Down 0.22%

Key numbers

Management commentary